Hoda M. EL-EMSHATY1, Entsar A. SAAD2, Mona S. GOUIDA3, Zahraa R. ELSHAHAWY1,2
BIOCELL, Vol.42, No.2, pp. 55-60, 2018, DOI:10.32604/biocell.2018.07009
Abstract Hepatitis C virus (HCV)-cirrhotic patients have the highest threat of developing hepatocellular carcinoma
(HCC) and may be at risk of extra hepatic cancer. The present study was designed to investigate CD133 and CK19 in
HCV (genotype-4)-cirrhotic patients with/without HCC or extra hepatic cancer, to assess the degree of their correlation
with cell cycle abnormalities and finally to assess the role of their combination as diagnostic tool for discrimination of
cirrhotic patients with HCC from those with extra hepatic cancer. The study included 77 HCV-cirrhotic patients and
20 healthy non-disease control group. Patients were categorized… More >
Login
Register
